Molecular characterisation of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli isolates from hospital and ambulatory patients in Germany

Veterinary Microbiology

Volumn 200, Issue , 2017, Pages 130-137

  Pietsch, Michael ^a   Eller, Christoph ^b   Wendt, Constanze ^c   Holfelder, Martin ^c   Falgenhauer, Linda ^d   Fruth, Angelika ^a   Grössl, Tobias ^a   Leistner, Rasmus ^e   Valenza, Giuseppe ^f   Werner, Guido ^a   Pfeifer, Yvonne ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^c Labor Limbach   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f Bavarian Health and Food Safety Authority   (Germany)

Author keywords

CTX M 15; Multidrug resistance; Nosocomial infection; Phylogroup B2; ST131

Indexed keywords

CEPHALOSPORIN DERIVATIVE; BETA LACTAMASE; BETA-LACTAMASE TEM-3;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLONE; CONTROLLED STUDY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; GENOTYPE; GERMANY; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; POLYMERASE CHAIN REACTION; ANIMAL; BACTERIUM IDENTIFICATION; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; OUTPATIENT DEPARTMENT; PREVALENCE;

AMBULATORY CARE FACILITIES; ANIMALS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; GERMANY; HOSPITALS; HUMANS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PREVALENCE;

EID: 84949422299     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2015.11.028     Document Type: Article

References (40)

1. Banerjee, R., Robicsek, A., Kuskowski, M.A., Porter, S., Johnston, B.D., Sokurenko, E., Tchesnokova, V., Price, L.B., Johnson, J.R., Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-beta-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010. Antimicrob. Agents Chemother. 57 (2013), 6385–6388.
2. Bankevich, A., Nurk, S., Antipov, D., Gurevich, A.A., Dvorkin, M., Kulikov, A.S., Lesin, V.M., Nikolenko, S.I., Pham, S., Prjibelski, A.D., Pyshkin, A.V., Sirotkin, A.V., Vyahhi, N., Tesler, G., Alekseyev, M.A., Pevzner, P.A., SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 19 (2012), 455–477.
3. Blanco, M., Alonso, M.P., Nicolas-Chanoine, M.H., Dahbi, G., Mora, A., Blanco, J.E., Lopez, C., Cortes, P., Llagostera, M., Leflon-Guibout, V., Puentes, B., Mamani, R., Herrera, A., Coira, M.A., Garcia-Garrote, F., Pita, J.M., Blanco, J., Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 63 (2009), 1135–1141.
4. Brolund, A., Edquist, P.J., Makitalo, B., Olsson-Liljequist, B., Soderblom, T., Wisell, K.T., Giske, C.G., Epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in Sweden 2007–2011. Clin. Microbiol. Infect. 20 (2014), O344–352.
5. Carattoli, A., Plasmids and the spread of resistance. Int. J. Med. Microbiol. 303 (2013), 298–304.
6. Cassier, P., Lallechere, S., Aho, S., Astruc, K., Neuwirth, C., Piroth, L., Chavanet, P., Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M beta-lactamase-producing Escherichia coli: a case–control study in a French teaching hospital. Clin. Microbiol. Infect. 17 (2011), 1746–1751.
7. Clermont, O., Bonacorsi, S., Bingen, E., Rapid and simple determination of the Escherichia coli Phylogenetic Group. Appl. Environ. Microbiol., 66, 2000, 4555.
8. Denisuik, A.J., Lagace-Wiens, P.R., Pitout, J.D., Mulvey, M.R., Simner, P.J., Tailor, F., Karlowsky, J.A., Hoban, D.J., Adam, H.J., Zhanel, G.G., Canadian Antimicrobial Resistance, A., Molecular epidemiology of extended-spectrum beta-lactamase., AmpC beta-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007–11. J. Antimicrob. Chemother. 68:Suppl. 1 (2013), i57–65.
9. Dimou, V., Dhanji, H., Pike, R., Livermore, D.M., Woodford, N., Characterization of Enterobacteriaceae producing OXA-48-like carbapenemases in the UK. J Antimicrob. Chemother. 67 (2012), 1660–1665.
10. ECDC, 2013. Antimicrobial Resistance Surveillance in Europe 2012 Annual report of the European Antimicrobial resistance Surveillance Network (EARS-net) (Stockholm, ECDC).
11. Eller, C., Simon, S., Miller, T., Frick, J.S., Prager, R., Rabsch, W., Guerra, B., Werner, G., Pfeifer, Y., Presence of beta-lactamases in extended-spectrum-cephalosporin-resistant Salmonella enterica of 30 different serovars in Germany 2005–11. J. Antimicrob. Chemother. 68 (2013), 1978–1981.
12. Ewers, C., Grobbel, M., Stamm, I., Kopp, P.A., Diehl, I., Semmler, T., Fruth, A., Beutlich, J., Guerra, B., Wieler, L.H., Guenther, S., Emergence of human pandemic O25:H4-ST131CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J. Antimicrob. Chemother. 65 (2010), 651–660.
13. Fernandes, R., Amador, P., Oliveira, C., Prudencio, C., Molecular characterization of ESBL-producing Enterobacteriaceae in northern Portugal. Sci. World J., 2014, 782897.
14. Fischer, J., Rodriguez, I., Baumann, B., Guiral, E., Beutin, L., Schroeter, A., Kaesbohrer, A., Pfeifer, Y., Helmuth, R., Guerra, B., blaCTX-M-(1)(5)-carrying Escherichia coli and Salmonella isolates from livestock and food in Germany. J. Antimicrob. Chemother. 69 (2014), 2951–2958.
15. García-Cobos, S., Köck, R., Mellmann, A., Frenzel, J., Friedrich, A.W., Rossen, J.W., Molecular yyping of Enterobacteriaceae from pig holdings in North-Western Germany reveals extended-spectrum and AmpC β-lactamases producing but no carbapenem resistant ones. PLoS One, 10(7), 2015, e0134533.
16. Garrido, A., Seral, C., Gude, M.J., Casado, C., Gonzalez-Dominguez, M., Saenz, Y., Castillo, F.J., Characterization of plasmid-mediated beta-lactamases in fecal colonizing patients in the hospital and community setting in Spain. Microb. Drug Resist. 20 (2014), 301–304.
17. Giufre, M., Graziani, C., Accogli, M., Luzzi, I., Busani, L., Cerquetti, M., Escherichia coli study Group, Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy. J. Antimicrob. Chemother. 67 (2012), 860–867.
18. Goullet, P., Picard, B., Highly pathogenic strains of Escherichia coli revealed by the distinct electrophoretic patterns of carboxylesterase B. J. Gen. Microbiol. 132 (1986), 1853–1858.
19. Hansen, F., Olsen, S.S., Heltberg, O., Justesen, U.S., Fuglsang-Damgaard, D., Knudsen, J.D., Hammerum, A.M., Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark. Microb. Drug Resist. 20 (2014), 316–324.
20. Hordijk, J., Mevius, D.J., Kant, A., Bos, M.E., Graveland, H., Bosman, A.B., Hartskeerl, C.M., Heederik, D.J., Wagenaar, J.A., Within-farm dynamics of ESBL/AmpC-producing Escherichia coli in veal calves: a longitudinal approach. J. Antimicrob. Chemother. 68 (2013), 2468–2476.
21. Johnson, J.R., Stell, A.L., Extended virulence genotypes of Escherichia coli. strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181 (2000), 261–272.
22. Johnson, J.R., Clermont, O., Johnston, B., Clabots, C., Tchesnokova, V., Sokurenko, E., Junka, A.F., Maczynska, B., Denamur, E., Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. J. Clin. Microbiol. 52 (2014), 1358–1365.
23. Larsen, M.V., Cosentino, S., Rasmussen, S., Friis, C., Hasman, H., Marvig, R.L., Jelsbak, L., Sicheritz-Ponten, T., Ussery, D.W., Aarestrup, F.M., Lund, O., Multilocus sequence typing of total-genome-sequenced bacteria. J. Clin. Microbiol. 50 (2012), 1355–1361.
24. Leistner, R., Meyer, E., Gastmeier, P., Pfeifer, Y., Eller, C., Dem, P., Schwab, F., Risk factors associated with the community-acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia coli. an exploratory case–control study. PLoS One, 8, 2013, e74323.
25. Livermore, D.M., Hawkey, P.M., CTX-M: changing the face of ESBLs in the UK. J. Antimicrob. Chemother. 56 (2005), 451–454.
26. Lopez-Cerero, L., Egea, P., Serrano, L., Navarro, D., Mora, A., Blanco, J., Doi, Y., Paterson, D.L., Rodriguez-Bano, J., Pascual, A., Characterisation of clinical and food animal Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase belonging to ST410 phylogroup A. Int. J. Antimicrob. Agents 37 (2011), 365–367.
27. Mathers, A.J., Peirano, G., Pitout, J.D., The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin. Microbiol. Rev. 28 (2015), 565–591.
28. Naseer, U., Sundsfjord, A., The CTX-M conundrum: dissemination of plasmids and E. coli clones. Microb. Drug Resist. 17 (2011), 83–97.
29. Oteo, J., Diestra, K., Juan, C., Bautista, V., Novais, A., Perez-Vazquez, M., Moya, B., Miro, E., Coque, T.M., Oliver, A., Canton, R., Navarro, F., Campos, J., Spanish Network in Infectious Pathology Projekt (REIPI), Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int. J. Antimicrob. Agents 34 (2009), 173–176.
30. Peirano, G., Asensi, M.D., Pitondo-Silva, A., Pitout, J.D., Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from Rio de Janeiro, Brazil. Clin. Microbiol. Infect. 17 (2011), 1039–1043.
31. Peirano, G., van der Bij, A.K., Gregson, D.B., Pitout, J.D., Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum beta-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region. J. Clin. Microbiol. 50 (2012), 294–299.
32. Pfeifer, Y., Cullik, A., Witte, W., Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int. J. Med. Microbiol. 300 (2010), 371–379.
33. Rodriguez, I., Thomas, K., Van Essen, A., Schink, A.K., Day, M., Chattaway, M., Wu, G., Mevius, D., Helmuth, R., Guerra, B., SAFEFOODERA-ESBL consortium, Chromosomal location of blaCTX-M genes in clinical isolates of Escherichia coli from Germany, The Netherlands and the UK. Int. J. Antimicrob. Agents 43 (2014), 553–557.
34. Rogers, B.A., Sidjabat, H.E., Paterson, D.L., Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66 (2011), 1–14.
35. Schink, A.K., Kadlec, K., Kaspar, H., Mankertz, J., Schwarz, S., Analysis of extended-spectrum-beta-lactamase-producing Escherichia coli isolates collected in the GERM-Vet monitoring programme. J. Antimicrob. Chemother. 68 (2013), 1741–1749.
36. Smet, A., Martel, A., Persoons, D., Dewulf, J., Heyndrickx, M., Claeys, G., Lontie, M., Van Meensel, B., Herman, L., Haesebrouck, F., Butaye, P., Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb. Drug Resist. 16 (2010), 129–134.
37. Valentin, L., Sharp, H., Hille, K., Seibt, U., Fischer, J., Pfeifer, Y., Michael, G.B., Nickel, S., Schmiedel, J., Falgenhauer, L., Friese, A., Bauerfeind, R., Roesler, U., Imirzalioglu, C., Chakraborty, T., Helmuth, R., Valenza, G., Werner, G., Schwarz, S., Guerra, B., Appel, B., Kreienbrock, L., Kasbohrer, A., Subgrouping of ESBL-producing Escherichia coli from animal and human sources: an approach to quantify the distribution of ESBL types between different reservoirs. Int. J. Med. Microbiol. 304 (2014), 805–816.
38. Valenza, G., Nickel, S., Pfeifer, Y., Eller, C., Krupa, E., Lehner-Reindl, V., Holler, C., Extended-spectrum-beta-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob. Agents Chemother. 58 (2014), 1228–1230.
39. Voets, G.M., Platteel, T.N., Fluit, A.C., Scharringa, J., Schapendonk, C.M., Stuart, J.C., Bonten, M.J., Hall, M.A., National, ESBL Surveillance Working Group, Population distribution of Beta-lactamase conferring resistance to third-generation cephalosporins in human clinical Enterobacteriaceae in the Netherlands. PLoS One, 7, 2012, e52102.
40. Wirth, T., Falush, D., Lan, R., Colles, F., Mensa, P., Wieler, L.H., Karch, H., Reeves, P.R., Maiden, M.C., Ochman, H., Achtman, M., Sex and virulence in Escherichia coli: an evolutionary perspective. Mol. Microbiol. 60 (2006), 1136–1151.